As of Aug 28
| +0.37 / +0.37%|
The 5 analysts offering 12-month price forecasts for China Biologic Products Inc have a median target of 140.00, with a high estimate of 149.00 and a low estimate of 125.00. The median estimate represents a +39.71% increase from the last price of 100.21.
The current consensus among 5 polled investment analysts is to Buy stock in China Biologic Products Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.